A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4162-4174

  Bolinger, Beatrice ^a   Sims, Stuart ^a   O'Hara, Geraldine ^a   De Lara, Catherine ^a   Tchilian, Elma ^a   Firner, Sonja ^b   Engeler, Daniel ^b   Ludewig, Burkhard ^b   Klenerman, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEASOME;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; FLOW CYTOMETRY; GENE DOSAGE; KINETICS; LIVER; LUNG PARENCHYMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENETIC VECTORS; IMMUNOLOGIC MEMORY; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUROMEGALOVIRUS; RECOMBINANT PROTEINS;

EID: 84876012968     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202665     Document Type: Article

References (53)

1. O'Hara, G. A., S. P. Welten, P. Klenerman, and R. Arens. 2012. Memory T cell inflation: understanding cause and effect. Trends Immunol. 33: 84-90.
2. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758-761.
3. Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12: 492-499.
4. Karrer, U., S. Sierro, M. Wagner, A. Oxenius, H. Hengel, U. H. Koszinowski, R. E. Phillips, and P. Klenerman. 2003. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J. Immunol. 170: 2022-2029.
5. Hansen, S. G., J. C. Ford, M. S. Lewis, A. B. Ventura, C. M. Hughes, L. Coyne-Johnson, N. Whizin, K. Oswald, R. Shoemaker, T. Swanson, et al. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-527.
6. Holtappels, R., M. F. Pahl-Seibert, D. Thomas, and M. J. Reddehase. 2000. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J. Virol. 74: 11495-11503.
7. Komatsu, H., S. Sierro, A. V. Cuero, and P. Klenerman. 2003. Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin. Exp. Immunol. 134: 9-12.
8. Northfield, J., M. Lucas, H. Jones, N. T. Young, and P. Klenerman. 2005. Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with 'memory inflation' in human cytomegalovirus infection. Immunol. Cell Biol. 83: 182-188.
9. Snyder, C. M., K. S. Cho, E. L. Bonnett, S. van Dommelen, G. R. Shellam, and A. B. Hill. 2008. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29: 650-659.
10. Sierro, S., R. Rothkopf, and P. Klenerman. 2005. Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection. Eur. J. Immunol. 35: 1113-1123.
11. Sylwester, A. W., B. L. Mitchell, J. B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P. R. Sleath, K. H. Grabstein, N. A. Hosken, F. Kern, et al. 2005. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673-685.
12. Munks, M. W., K. S. Cho, A. K. Pinto, S. Sierro, P. Klenerman, and A. B. Hill. 2006. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J. Immunol. 177: 450-458.
13. Munks, M. W., M. C. Gold, A. L. Zajac, C. M. Doom, C. S. Morello, D. H. Spector, and A. B. Hill. 2006. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J. Immunol. 176: 3760-3766.
14. Hutchinson, S., S. Sims, G. O'Hara, J. Silk, U. Gileadi, V. Cerundolo, and P. Klenerman. 2011. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS ONE 6: e14646.
15. Snyder, C. M., K. S. Cho, E. L. Bonnett, J. E. Allan, and A. B. Hill. 2011. Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog. 7: e1002295.
16. Walton, S. M., N. Torti, S. Mandaric, and A. Oxenius. 2011. T-cell help permits memory CD8(+) T-cell inflation during cytomegalovirus latency. Eur. J. Immunol. 41: 2248-2259.
17. Isa, A., V. Kasprowicz, O. Norbeck, A. Loughry, K. Jeffery, K. Broliden, P. Klenerman, T. Tolfvenstam, and P. Bowness. 2005. Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med. 2: e343.
18. Lang, A., J. D. Brien, and J. Nikolich-Zugich. 2009. Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens. J. Immunol. 183: 8077-8087.
19. Simmons, R., C. Sharp, S. Sims, H. Kloverpris, P. Goulder, P. Simmonds, P. Bowness, and P. Klenerman. 2011. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J. Infect. Dis. 203: 1378-1387.
20. Swanson, P. A., II, A. R. Hofstetter, J. J. Wilson, and A. E. Lukacher. 2009. Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection. J. Immunol. 182: 5198-5202.
21. Barnes, E., A. Folgori, S. Capone, L. Swadling, S. Aston, A. Kurioka, J. Meyer, R. Huddart, K. Smith, R. Townsend, et al. 2012. Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci. Transl. Med. 4: 115ra111.
22. Singh, S., H. Toro, D. C. Tang, W. E. Briles, L. M. Yates, R. T. Kopulos, and E. W. Collisson. 2010. Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes. Virology 405: 62-69.
23. Zhang, H. G., Y. M. Wang, J. F. Xie, X. Liang, H. C. Hsu, X. Zhang, J. Douglas, D. T. Curiel, and J. D. Mountz. 2001. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus. Gene Ther. 8: 704-712.
24. Ziegler, R. J., C. Li, M. Cherry, Y. Zhu, D. Hempel, N. van Rooijen, Y. A. Ioannou, R. J. Desnick, M. A. Goldberg, N. S. Yew, and S. H. Cheng. 2002. Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease. Hum. Gene Ther. 13: 935-945.
25. Bassett, J. D., S. L. Swift, and J. L. Bramson. 2011. Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors. Expert Rev. Vaccines 10: 1307-1319.
26. Holst, P. J., C. Ørskov, A. R. Thomsen, and J. P. Christensen. 2010. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination. J. Immunol. 184: 4431-4439.
27. Kaufman, D. R., M. Bivas-Benita, N. L. Simmons, D. Miller, and D. H. Barouch. 2010. Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes. J. Virol. 84: 5986-5996.
28. Krebs, P., E. Scandella, B. Odermatt, and B. Ludewig. 2005. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus. J. Immunol. 174: 4559-4566.
29. Bassett, J. D., T. C. Yang, D. Bernard, J. B. Millar, S. L. Swift, A. J. McGray, H. VanSeggelen, J. E. Boudreau, J. D. Finn, R. Parsons, et al. 2011. CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells. Blood 117: 1146-1155.
30. Finn, J. D., J. Bassett, J. B. Millar, N. Grinshtein, T. C. Yang, R. Parsons, C. Evelegh, Y. Wan, R. J. Parks, and J. L. Bramson. 2009. Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus. J. Virol. 83: 12027-12036.
31. Tatsis, N., J. C. Fitzgerald, A. Reyes-Sandoval, K. C. Harris-McCoy, S. E. Hensley, D. Zhou, S. W. Lin, A. Bian, Z. Q. Xiang, A. Iparraguirre, et al. 2007. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110: 1916-1923.
32. Manning, W. C., and E. S. Mocarski. 1988. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology 167: 477-484.
33. Ludewig, B., A. F. Ochsenbein, B. Odermatt, D. Paulin, H. Hengartner, and R. M. Zinkernagel. 2000. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med. 191: 795-804.
34. Köntgen, F., G. Süss, C. Stewart, M. Steinmetz, and H. Bluethmann. 1993. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5: 957-964.
35. Bolinger, B., P. Krebs, Y. Tian, D. Engeler, E. Scandella, S. Miller, D. C. Palmer, N. P. Restifo, P. A. Clavien, and B. Ludewig. 2008. Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. Blood 111: 4588-4595.
36. Fehling, H. J., W. Swat, C. Laplace, R. Kühn, K. Rajewsky, U. Müller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265: 1234-1237.
37. Overwijk, W. W., D. R. Surman, K. Tsung, and N. P. Restifo. 1997. Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens. Methods 12: 117-123.
38. Oukka, M., M. Cohen-Tannoudji, Y. Tanaka, C. Babinet, and K. Kosmatopoulos. 1996. Medullary thymic epithelial cells induce tolerance to intracellular proteins. J. Immunol. 156: 968-975.
39. Gold, M. C., M. W. Munks, M. Wagner, U. H. Koszinowski, A. B. Hill, and S. P. Fling. 2002. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J. Immunol. 169: 359-365.
40. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
41. Torti, N., S. M. Walton, T. Brocker, T. Rülicke, and A. Oxenius. 2011. Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog. 7: e1002313.
42. Yang, T.C., J. Millar, T. Groves, W. Zhou, N. Grinshtein, R. Parsons, C. Evelegh, Z. Xing, Y. Wan, and J. Bramson. 2007. On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines. Mol Ther 15: 997-1006.
43. Harty, J. T., and V. P. Badovinac. 2008. Shaping and reshaping CD8+ T-cell memory. Nat. Rev. Immunol. 8: 107-119.
44. Wiesel, M., S. Walton, K. Richter, and A. Oxenius. 2009. Virus-specific CD8 T cells: activation, differentiation and memory formation. APMIS 117: 356-381.
45. Snyder, C. M., A. Loewendorf, E. L. Bonnett, M. Croft, C. A. Benedict, and A. B. Hill. 2009. CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection. J. Immunol. 183: 3932-3941.
46. Holst, P. J., C. Bartholdy, A. Stryhn, A. R. Thomsen, and J. P. Christensen. 2007. Rapid and sustained CD4(+) T-cell-independent immunity from adenovirus-encoded vaccine antigens. J. Gen. Virol. 88: 1708-1716.
47. Yang, T. C., J. B. Millar, N. Grinshtein, J. Bassett, J. Finn, and J. L. Bramson. 2007. T-cell immunity generated by recombinant adenovirus vaccines. Expert Rev. Vaccines 6: 347-356.
48. Seckert, C. K., S. I. Schader, S. Ebert, D. Thomas, K. Freitag, A. Renzaho, J. Podlech, M. J. Reddehase, and R. Holtappels. 2011. Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T-cells but are not sufficient for driving memory inflation during viral latency. J. Gen. Virol. 92: 1994-2005.
49. Mercer, J. A., C. A. Wiley, and D. H. Spector. 1988. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62: 987-997.
50. Seckert, C. K., A. Renzaho, H. M. Tervo, C. Krause, P. Deegen, B. Kühnapfel, M. J. Reddehase, and N. K. Grzimek. 2009. Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J. Virol. 83: 8869-8884.
51. Marquardt, A., S. Halle, C. K. Seckert, N. A. Lemmermann, T. Z. Veres, A. Braun, U. A. Maus, R. Förster, M. J. Reddehase, M. Messerle, and A. Busche. 2011. Single cell detection of latent cytomegalovirus reactivation in host tissue. J. Gen. Virol. 92: 1279-1291.
52. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
53. Wherry, E. J., V. Teichgräber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.